A study of carotid intima-media thickness in GH-deficient Japanese adults during onset among adults and children

European Journal of Endocrinology

Volumn 148, Issue 3, 2003, Pages 333-338

  Murata, Masahiro ^a   Kaji, Hidesuke ^b   Mizuno, Ishikazu ^a   Sakurai, Tatsuya ^a   Iida, Keiji ^a   Okimura, Yasuhiko ^a   Chihara, Kazuo ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Department of Physiology and Biochemistry   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DESMOPRESSIN; GROWTH HORMONE; HYDROCORTISONE; LIPID; LIPOPROTEIN; SEX HORMONE; SOMATOMEDIN C; THYROXINE; TRIACYLGLYCEROL;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; BODY MASS; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; HYPOGONADISM; HYPOPITUITARISM; INTERNAL CAROTID ARTERY; JAPAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; ONSET AGE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGE OF ONSET; ARTERIOSCLEROSIS; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CAROTID BODY; DISEASE PROGRESSION; FEMALE; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; JAPAN; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED;

EID: 0037360238     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1480333     Document Type: Article

References (29)

1. Rosen T & Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990 336 285-288.
2. Markussis V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN & Johnston DG. Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet 1992 340 1188-1192.
3. Capaldo B, Patti L, Oliviero U, Longobardi S, Pardo F, Vitale F et al. Increased arterial intima-media thickness in childhood-onset growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 1997 82 1378-1381.
4. Borson-Chazot F, Serusclat A, Kalfallah Y, Ducottet X, Sassolas G, Bernard S et al. Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency. Journal of Clinical Endocrinology and Metabolism 1999 84 1329-1333.
5. Merimee TJ, Hollander W & Fineberg SE. Studies of hyperlipidemia in the HGH-deficient state. Metabolism: Clinical and Experimental 1972 21 1053-1061.
6. Libber SM, Plotnik LP, Johanson AJ, Blizzard RM, Kwiterovich PO & Migeon CJ. Long-term follow-up of hypopituitary patients treated with human growth hormone. Medicine 1990 69 46-55.
7. Rosen T, Eden S, Larson G, Wilhelmsen L & Bengtsson B-Å. Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinologica 1993 129 195-200.
8. DeBoer H, Blok GJ, Voerman HJ, Philips M & Schouten JA. Serum lipid levels in growth hormone-deficient men. Metabolism: Clinical and Experimental 1994 43 199-202.
9. Cuneo RC, Salomon F, Watts GF, Hesp R & Sönksen PH. Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metabolism: Clinical and Experimental 1993 42 1519-1523.
10. Snel YEM, Doerga ME, Brummer RJM, Zelissen PMJ & Koppeschaar HPF. Magnetic resonance imaging-assessed adipose tissue and serum lipid and insulin concentrations in growth hormone-deficient adults. Arteriosclerosis, Thrombosis, and Vascular Biology 1995 15 1543-1548.
11. Alford F, Hew FL, Koschmann M, Cristopher M, Rantzau C & Ward G. Defects of glucose metabolism in growth hormone-deficient (GHD) adults. Endocrinology and Metabolism 1994 1 (Suppl B) 27.
12. O'Neal DN, Kalfas A, Dunning PL, Christopher MJ, Sawyer SD, Ward GM et al. The effect of 3 months of recombinant human growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: a minimal model analysis. Journal of Clinical Endocrinology and Metabolism 1994 79 975-983.
13. Hew FL, Koschmann M, Christopher M, Rantzau C, Vaag A, Ward G et al. Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity. Journal of Clinical Endocrinology and Metabolism 1996 81 555-564.
14. Whitehead HM, Boreham C, McIlrath EM, Sheridan B, Kennedy L, Atkinson AB et al. Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clinical Endocrinology 1992 36 45-52.
15. Beshyah SA, Freemantle C, Shahi M, Anyaoku V, Merson S, Lynch S et al. Replacement treatment with biosynthetic growth hormone in growth hormone-deficient hypopituitary adults. Clinical Endocrinology 1995 42 73-84.
16. Amato G, Carella C, Fazio S, La Montagna G, Cittadini A, Sabatini D et al. Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. Journal of Clinical Endocrinology and Metabolism 1993 77 1671-1676.
17. Nass R, Huber RM, Klauss V, Muller OA, Schopohl J & Strasburger CJ. Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood. Journal of Clinical Endocrinology and Metabolism 1995 80 552-557.
18. Rutherford OM, Beshyah SA, Scon J, Watkins Y & Johnston DG. Contractile properties of the quadriceps muscle in growth hormone-deficient hypopituitary adults. Clinical Science 1995 88 67-71.
19. Valcavi R, Gaddi O, Zini M, Iavicoli M, Mellino U & Portioli I. Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment. Journal of Clinical Endocrinology and Metabolism 1995 80 659-666.
20. McGauley GA. Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency. Acta Pediatrica Scandinavica 1989 356 70-72.
21. Mardh G, Lundin K, Borg G, Jonsson B & Lindeberg A. Growth hormone replacement therapy in adult hypopituitary patients with growth hormone deficiency: combined data from 12 European placebo-controlled clinical trials. Endocrinology and Metabolism 1994 1 (Suppl A) 43-49.
22. Attanasio AF, Lamberts WJS, Matranga MCA, Birkett MA, Bates PC & Valk NK. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Journal of Clinical Endocrinology and Metabolism 1997 82 82-88.
23. Yamasaki Y, Kawamori R, Matsushima H, Nishizawa H, Kodama M, Kajimoto Y et al. Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging. Diabetes 1994 43 634-639.
24. Irie M, Shizume K, Takano K, Kato Y, Tanaka T & Chihara K. Growth hormone replacement therapy in adults with growth hormone deficiency: a double blind, placebo-controlled crossover trial in Japan. Endocrinology and Metabolism 1995 2 17-23.
25. Powrie J, Weissberger A & Sönksen P. Growth hormone replacement therapy for growth hormone-deficient adults. Drugs 1995 49 656-663.
26. Pignoli P, Tremoli E, Poli A, Oreste P & Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986 74 1399-1406.
27. Bonithon-Kopp C, Touboul P-J, Berr C, Leroux C, Mainard F, Courbon D et al. Relation of intima-media thickness to atherosclerotic plaques in carotid arteries. The vascular aging (EVA) study. Arteriosclerosis, Thrombosis, and Vascular Biology 1996 16 310-316.
28. Tsukahara H, Gordienko DV, Tonshoff B, Gelalto MC & Goligorsky MS. Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney International 1994 45 598-604.
29. Böger RH, Skamira C, Bode-Böger SM, Brabant G & Mühlen A. Nitric oxide may mediate hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study. Journal of Clinical Investigation 1996 98 2706-2713.